Steven B Miller
CIK 1599611 · EVP, Chief Clinical Officer · last filed 2026-05-07
Steven B Miller is an EVP, Chief Clinical Officer who has filed 38 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for BTSGU, was dated May 7, 2026. Across all open-market trades the lifetime net is −$6.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $14.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ST. LOUIS, MO 63121
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BTSGU | Director | 23,106 | $207.52 | $4.79M | $0 | 4 | 2026-05-07 |
| CI | EVP, Chief Clinical Officer | 31,377 | $304.37 | $9.55M | -$3.40M | 11 | 2021-03-02 |
| Express Scripts Holding Co. (ESRX) Delisted | Sr. VP & Chief Med. Officer | 0 | — | — | -$3.03M | 23 | 2018-12-21 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-07 | BTSGU | Grant (A) | +4,983 | $0 | EDGAR |
| 2025-11-06 | BTSGU | Tax (F) | −4,497 | -$147.0K | EDGAR |
| 2025-05-07 | BTSGU | Grant (A) | +11,912 | $0 | EDGAR |
| 2024-11-08 | BTSGU | Grant (A) | +10,708 | $0 | EDGAR |
| 2021-03-02 | CI | Mixed | +893 | -$617.5K | EDGAR |
| 2021-02-26 | CI | Grant (A) | +1,287 | $0 | EDGAR |
| 2021-02-08 | CI | Tax (F) | −622 | -$130.9K | EDGAR |
| 2021-01-08 | CI | Mixed | +777 | -$317.8K | EDGAR |
| 2020-03-02 | CI | Mixed | −255 | -$442.5K | EDGAR |
| 2020-02-28 | CI | Grant (A) | +1,433 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.